Cargando…
How to develop therapeutic and translational research collaborations with industry
Discovery and development of new medicines requires the talent and passion of both academic and industrial scientists. Identifying the optimal set of circumstances for direct collaboration between academic and industry teams requires a mutual understanding of what each partner brings to the relation...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789159/ https://www.ncbi.nlm.nih.gov/pubmed/31609671 http://dx.doi.org/10.1091/mbc.E19-05-0261 |
_version_ | 1783458591728992256 |
---|---|
author | Kleiman, Robin J. Ehlers, Michael D. |
author_facet | Kleiman, Robin J. Ehlers, Michael D. |
author_sort | Kleiman, Robin J. |
collection | PubMed |
description | Discovery and development of new medicines requires the talent and passion of both academic and industrial scientists. Identifying the optimal set of circumstances for direct collaboration between academic and industry teams requires a mutual understanding of what each partner brings to the relationship, and an appreciation of the specialized capabilities and scope of work to be undertaken by each group. We provide our perspective on the who, what, where, why, and how for establishing therapeutic and translational research collaborations between academic and industry scientists. |
format | Online Article Text |
id | pubmed-6789159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The American Society for Cell Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-67891592019-12-30 How to develop therapeutic and translational research collaborations with industry Kleiman, Robin J. Ehlers, Michael D. Mol Biol Cell Perspectives Discovery and development of new medicines requires the talent and passion of both academic and industrial scientists. Identifying the optimal set of circumstances for direct collaboration between academic and industry teams requires a mutual understanding of what each partner brings to the relationship, and an appreciation of the specialized capabilities and scope of work to be undertaken by each group. We provide our perspective on the who, what, where, why, and how for establishing therapeutic and translational research collaborations between academic and industry scientists. The American Society for Cell Biology 2019-10-15 /pmc/articles/PMC6789159/ /pubmed/31609671 http://dx.doi.org/10.1091/mbc.E19-05-0261 Text en © 2019 Kleiman and Ehlers. “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society for Cell Biology. http://creativecommons.org/licenses/by-nc-sa/3.0 This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License. |
spellingShingle | Perspectives Kleiman, Robin J. Ehlers, Michael D. How to develop therapeutic and translational research collaborations with industry |
title | How to develop therapeutic and translational research collaborations with industry |
title_full | How to develop therapeutic and translational research collaborations with industry |
title_fullStr | How to develop therapeutic and translational research collaborations with industry |
title_full_unstemmed | How to develop therapeutic and translational research collaborations with industry |
title_short | How to develop therapeutic and translational research collaborations with industry |
title_sort | how to develop therapeutic and translational research collaborations with industry |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789159/ https://www.ncbi.nlm.nih.gov/pubmed/31609671 http://dx.doi.org/10.1091/mbc.E19-05-0261 |
work_keys_str_mv | AT kleimanrobinj howtodeveloptherapeuticandtranslationalresearchcollaborationswithindustry AT ehlersmichaeld howtodeveloptherapeuticandtranslationalresearchcollaborationswithindustry |